Stanford Medicine
Subscribe to Stanford Medcast, where we bring insights from the world’s leading physicians and scientists on hot topics in medicine, healthcare, and education. Available on Medcast.stanford.edu and wherever you listen to podcasts.
Oncology and Hematology
Stanford Medicine
Pediatric R/R ALK+ ALCL: Treatment and Outcomes in the Targeted Drug Era
FEATURING
Lianna Marks
- March 20, 2025
Stanford Medicine
2025 Updates in HER2+ mBC: 1L, 2L, and Beyond (With a Focus on Brain Mets)
FEATURING
Milana Dolezal
- 89 views
- February 27, 2025
- 3
Stanford Medicine
Optimal Therapy Sequence for 1L Treatment of BRAF-Mutated Metastatic Melanoma
FEATURING
Allison Betof Warner
- 75 views
- February 14, 2025
- 1
2024 SABCS Annual Meeting Insights Hub
SABCS 2024 Insights: Tumor Intrinsic and Extrinsic Characteristics of Invasive Lobular Carcinomas
FEATURING
Lise Mangiante
- 13 views
- February 7, 2025
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Dynamics of ctDNA and Outcomes With Liso-cel in R/R LBCL - Transcend NHL-001 Study
FEATURING
Caroline Lee
- 47 views
- December 18, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: CAR T-Cell Therapy in Octogenarians With R/R LBCL
FEATURING
Caroline Lee
- 69 views
- December 18, 2024
- 1
Stanford Medicine
Vorasidenib for Low Grade Gliomas
FEATURING
Toni Cao
- 150 views
- November 27, 2024
- 1
Stanford Medicine
Current Clinical Utility of ctDNA in Lymphomas
FEATURING
Joseph Schroers-Martin
- 31 views
- November 10, 2024
- 1
Insights from 2024 WCLC
WCLC 2024 Insights: Effect of De Novo Co-Mutations on Clinical Outcomes in Patients Receiving 1L Osimertinib for EGFRm mNSCLC
FEATURING
Fangdi Sun
- 30 views
- September 18, 2024
- 1
Stanford Medicine
Hot Flashes: Nonhormonal Options for Cancer Patients
FEATURING
Milana Dolezal
- 652 views
- September 18, 2024
- 7
Stanford Medicine
Sexual Health and Wellbeing in Women’s Cancer Survivors
FEATURING
Milana Dolezal
- 228 views
- July 10, 2024
- 4
Stanford Medicine
PKD: Diagnosis, Treatment and Monitoring for Complications
FEATURING
May Chien
- 529 views
- July 8, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
Management of Higher Risk eBC Including BRCAm, HER2- Subtypes
FEATURING
Milana Dolezal
- 406 views
- July 2, 2024
- 5
Stanford Medicine
Risk of Second Malignancies and T-Cell Lymphoma After CAR T-Cell Therapy
FEATURING
Mark Hamilton
- 224 views
- June 28, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanoma"
FEATURING
Allison Betof Warner
- 197 views
- June 11, 2024
Stanford Medicine
FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: The Era of TIL Therapy Is Here!
FEATURING
Allison Betof Warner
- 1,025 views
- March 11, 2024
- 7
Stanford Medicine
ADCs in HR+ Advanced/Metastatic BC
FEATURING
Milana Dolezal
- 308 views
- February 27, 2024
- 4
Stanford Medicine
HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sensitivity
FEATURING
Milana Dolezal
- 1,059 views
- February 27, 2024
- 7
Stanford Medicine
HR+ mBC: CDK4/6i Progression Management
FEATURING
Milana Dolezal
- 728 views
- February 27, 2024
- 4
Stanford Medicine
New Drugs for Small Cell Lung Cancer
FEATURING
Millie Das
- 362 views
- August 3, 2023
- 6
Stanford Medicine
Treatment of Brain Metastases in Advanced NSCLC
FEATURING
Nathaniel Myall
- 161 views
- January 28, 2023
- 2
Stanford Medicine
Stanford Medicine Historical Landscape of Testing: Blood-Based Diagnostic Biomarkers & Screening
FEATURING
John Leppert
- 38 views
- July 9, 2022
Stanford Medicine
Stanford Medicine Advances in Imaging to Improve Prostate Cancer Diagnosis
FEATURING
Geoffrey Sonn
- 2,873 views
- July 9, 2022
- 17
Stanford Medicine
Genetics/Genomics in Prostate Cancer
FEATURING
Matthew Cooperberg
- 97 views
- July 9, 2022
Stanford Medicine
Disparities in Prostate Cancer in the Era of Precision Medicine
FEATURING
Hala Borno
- 37 views
- July 9, 2022
Stanford Medicine
Brain Metastases Are Now More Treatable in HER2+ Metastatic Breast Cancer
FEATURING
Mark Pegram
- 339 views
- May 12, 2022
- 1
